A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Lung Neoplasms
  • Small Cell Lung Carcinoma

abstract

  • This regimen is well tolerated, and demonstrates activity in patients with advanced NSCLC.

publication date

  • June 2004

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdh215

PubMed ID

  • 15151948

Additional Document Info

start page

  • 915

end page

  • 20

volume

  • 15

number

  • 6